JANPIX
Janpix is discovering and developing inhibitors of Signal Transducer and Activator of Transcription (“STAT”) proteins. Most members of this family of transcription factors have been known for some time and their relevance in certain cancers, in particular for STAT3 & STAT5, validated. Inhibiting the function of STAT proteins though has been very challenging thus far and Janpix developed new chemistry to address this complex problem.
JANPIX
Industry:
App Discovery Biotechnology Therapeutics
Founded:
2013-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.janpixbio.com
Total Employee:
1+
Status:
Active
Total Funding:
27.67 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Office 365 Mail Microsoft Azure DNS GoDaddy DNS
Similar Organizations
Cellugy
Cellugy operates as a biotechnology startup.
iNNOHEALTH technology solutions
iNNOHEALTH operates as an health technology start up
Nitroterra
Nitroterra operates as a biotechnological startup.
Current Advisors List
Current Employees Featured
Founder
Investors List
Official Site Inspections
http://www.janpixbio.com
- Host name: 198.49.23.144
- IP address: 198.49.23.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
